Co-Founder of CanSino Biologics Qiu Dongxu delivers a speech on the progress of company's coronavirus vaccine candidate at the China Anti-viral Drug Innovation Summit, following the outbreak of the coronavirus disease , in Suzhou, Jiangsu province, China July 11, 2020. REUTERS/Roxanne Liu
He said its Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests. He said its new factory under construction in China will allow it to produce 100-200 million doses of coronavirus vaccines per year by early 2021.
I hope there's no more games in this talk.
'We are contacting and Russia, Brazil, Chile and Saudi Arabia (for the Phase III trial) and it's still in discussion,'
MastersOfNaming Òstia si és el Bartomeu
They have it already 🤗
Wassup with this trial overseas? Cant you just do in in China.. you have at least a billion people
Big Pharma at it again along with the Dems that seems to get a payout for the vaccine. Shady party to say the least
Im not getting any vaccine that comes from china thanks
How easy was for them to spread it .now they are talking about vaccine...doesn't it sound like plan they have being working on to become super power
Biotech is blowing up, let’s pump this market until we find a cure
This vaccine is developed in Canada, with the equipment and the technology of Canada’s National Research Council.
Let them take it and then we will see how that works out.
Yup...CHINA COMMNISTS didn't want to do the trials on their own PEOPLE, ODD, BUT TOOK THE TRIAL TO ... BRAZIL!
beware ! it must be fake !
I’ll pass on the Chinese vaccine and wait for an american or EU version
How many clinical trials these countries had ever done, before? I'd be very careful with the PⅠ,PⅡ report if I am a healthcare official from the listed countries.
🖕🏻everyone and everything chinese! It doesn’t even deserve to be capitalized! 🚫💩🇨🇳
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: Reuters - 🏆 2. / 97 Read more »
Source: Forbes - 🏆 394. / 53 Read more »